What's New:
Recent Quotes:
- $TTFS-TC 174.01 -0.04
- $XFL-ASX 4,725.70 30.70
- $IBC-BSP 9,370.51 -50.16
- $J200-FTSE 24,338.36 0.00
- $XTL-ASX 2,859.00 18.10
November 22, 2009 8:50:46 PM EST
- VIVUS INC (VVUS)
- Last: 8.42
- Chg: 0.08
- Time: N/A
- Overview
- |
- Charts
- |
- News
- |
- Profile
- |
- Financials
- |
- Holdings
- |
- Insider
- |
- Analysts
- |
- SEC Filings
- |
- Options
- |
- Message Board
VIVUS INC Headlines
Wednesday November 18, 2009
- VIVUS Reports Positive Results From Phase 3 Study Of Avanafil For Treating Male Impotence - Update
11:57:00 EST - VVUS: Management Discusses Positive Phase 3 Results re Avanafil for ED
11:19:00 EST - VIVUS To Present At Lazard Capital Markets Healthcare Conference; Webcast At 1:45 PM ET
10:37:00 EST - VVUS: Positive Results form Phase 3 Trial of Avanafil in Erectile Dysfunction
08:43:00 EST - VIVUS Reports Positive Results From Phase 3 Study Of Avanafil In Erectile Dysfunction - Quick Facts
06:41:00 EST - *VIVUS Reports Positive Results From REVIVE
06:31:00 EST - VIVUS Announces Positive Results From Phase 3 Study of Avanafil in Erectile Dysfunction; Data Demonstrate Robust Efficacy, Favorable Side-Effect Profile --Results Underscore Differentiating Profile; Indicate Significant Market Opportunity for Avanafil
06:30:00 EST
Tuesday November 17, 2009
Stocks Marketplace
- 10 Day Free Demo & Fully Functional Software
- Free Market Forecasts
- Why Do Some Know What To Trade, When? Get LiveCharts Real-Time Quotes, Charts, News.
- What Tools Can Take You To Pro-Level Trading Success? Discover The Answer With eSignal.
- How Do The Pros Make Successful Trades? eSignal Learning's Free Seminars Can Show You.
- How To Profit Using Pivot Points, Candlesticks, And Other Indicators